NCT06319859

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries

Name: Clinical Trial NCT06319859
Creator: Cairo University
Keywords: Pain, Postoperative, Morphine, Phase 3, drug, clinical trial, Egypt

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries: A Randomized Controlled Clinical Trial.

Cairo University·Phase 3·ClinicalTrials.gov·drugNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Pain, Postoperative
Drug/Device/Intervention: Morphine
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Cairo University
Location: Cairo, Egypt

Timeline & enrollment

Phase: Phase 3
Start date: Mar 01, 2024
End date: Oct 01, 2024
Enrollment: 50 participants

Primary outcome

Time to first analgesic requirement

Summary

This study will evaluate the efficacy and safety of intrathecal non-preservative-free morphine and its effect on pain in patients undergoing unilateral inguinal hernia surgeries.

ICD-10 classifications

During surgical operationDuring surgical operationDuring surgical operationPain, unspecifiedPostoperative intestinal obstruction

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06319859
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06319859 through Pure Global AI's free database. This Phase 3 trial is sponsored by Cairo University and is currently Not yet recruiting. The study focuses on Pain, Postoperative. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.